Product Information
TOLTERODINE TARTRATE 1 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2039 per EA under NDC 33342009709. Its NADAC has been published 525 times since Sep 14, 2016.
FDA first approved this application on Aug 31, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Tolterodine tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342009709
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TOLTERODINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203409FDA Approved
8/31/2015
TE Code
AB
On Market Since
10/8/2020
Pharmacological Classes
Price Statistics
The NADAC for TOLTERODINE TARTRATE 1 MG TAB has been published 525 times since Sep 14, 2016, and over the history we have for it it has declined 86.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2039 per EA |
|---|---|
| All-time high | $2.0447 (Nov 16, 2016) |
| All-time low | $0.1804 (Nov 20, 2024) |
| 52-week high | $0.2754 |
| 52-week low | $0.2000 |
| Median price | $0.6339 |
| Average price | $0.6332 |
| Largest weekly change | +55.6% (Oct 17, 2018) |
| Weeks tracked | 525 |
| Tracking since | Sep 14, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tolterodine tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOLTERODINE TARTRATE 1 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TOLTERODINE TARTRATE 1 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.2039 per EA (NDC 33342009709), effective Sep 30, 2026.
How has the price of TOLTERODINE TARTRATE 1 MG TAB changed over time?
Over the history we have for it, the NADAC for TOLTERODINE TARTRATE 1 MG TAB has declined 86.9%. It has been tracked across 525 weekly CMS publications since Sep 14, 2016.
What are the highest and lowest recorded NADAC prices for TOLTERODINE TARTRATE 1 MG TAB?
Since Sep 14, 2016, the NADAC for TOLTERODINE TARTRATE 1 MG TAB has ranged from a low of $0.1804 (Nov 20, 2024) to a high of $2.0447 (Nov 16, 2016), with a median of $0.6339 per EA.
Are there cheaper alternatives to TOLTERODINE TARTRATE 1 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOLTERODINE TARTRATE 1 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TOLTERODINE TARTRATE 1 MG TAB?
TOLTERODINE TARTRATE 1 MG TAB (NDC 33342009709) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.